OBJECTIVE: The secreted frizzled-related proteins (sFRPs) are reported to be antagonists of a number of tumors. This study was designed to investigate the relationship of sFRP4 with aggressiveness of pituitary adenomas. MATERIAL AND METHOD: Specimens were classified into three groups: normal control (n = 10), non-aggressive group (n = 42) and aggressive group (n = 26) according to preoperative magnetic resonance imaging (MRI)/computed tomography. sFRP4 were investigated by PCR, Western blotting, and immunohistochemistry (IHC). The methylation status of the sFRP4 promoter region was observed by MassArray. Cell culture and 5-aza-2-deoxycytidine treatment was performed to observe the relationship of downregulation of sFRP4 with methylation of the sFRP4 gene. RESULTS: PCR and Western blot results showed that sFRP4 expression was downregulated in aggressive pituitary adenomas, which was confirmed by IHC. Methylation of the sFRP4 promoter was increased in aggressive pituitary adenomas. And methylation of the sFRP4 promoter lead to downregulation of sFRP4 expression. CONCLUSIONS: sFRP4 expression is inversely related to the aggressiveness of pituitary adenomas, and act as a tumor suppressor.
OBJECTIVE: The secreted frizzled-related proteins (sFRPs) are reported to be antagonists of a number of tumors. This study was designed to investigate the relationship of sFRP4 with aggressiveness of pituitary adenomas. MATERIAL AND METHOD: Specimens were classified into three groups: normal control (n = 10), non-aggressive group (n = 42) and aggressive group (n = 26) according to preoperative magnetic resonance imaging (MRI)/computed tomography. sFRP4 were investigated by PCR, Western blotting, and immunohistochemistry (IHC). The methylation status of the sFRP4 promoter region was observed by MassArray. Cell culture and 5-aza-2-deoxycytidine treatment was performed to observe the relationship of downregulation of sFRP4 with methylation of the sFRP4 gene. RESULTS: PCR and Western blot results showed that sFRP4 expression was downregulated in aggressive pituitary adenomas, which was confirmed by IHC. Methylation of the sFRP4 promoter was increased in aggressive pituitary adenomas. And methylation of the sFRP4 promoter lead to downregulation of sFRP4 expression. CONCLUSIONS:sFRP4 expression is inversely related to the aggressiveness of pituitary adenomas, and act as a tumor suppressor.
Authors: Mihaela N Popescu; Elena Ionescu; L C Iovănescu; B V Cotoi; A I Popescu; Anca Elena Gănescu; Adina Glodeanu; Cristiana Geormăneanu; Andreiana Moraru; Anca Pătraşcu Journal: Rom J Morphol Embryol Date: 2013 Impact factor: 1.033
Authors: Elizabeth A Griffiths; Steven D Gore; Craig Hooker; Michael A McDevitt; Judith E Karp; B Douglas Smith; Helai P Mohammad; Ying Ye; James G Herman; Hetty E Carraway Journal: Leuk Lymphoma Date: 2010-09
Authors: Carmen J Marsit; Margaret R Karagas; Angeline Andrew; Mei Liu; Hadi Danaee; Alan R Schned; Heather H Nelson; Karl T Kelsey Journal: Cancer Res Date: 2005-08-15 Impact factor: 12.701
Authors: Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee Journal: Growth Factors Date: 2012-12-21 Impact factor: 2.511
Authors: Francis Jacob; Kristjan Ukegjini; Sheri Nixdorf; Caroline E Ford; Jake Olivier; Rosmarie Caduff; James P Scurry; Rea Guertler; Daniela Hornung; Renato Mueller; Daniel A Fink; Neville F Hacker; Viola A Heinzelmann-Schwarz Journal: PLoS One Date: 2012-02-21 Impact factor: 3.240